By editor
Originally published on Fri October 5, 2012 4:24 pm
The news that the cost of personal genome sequencing will soon drop as low as $1,000 has generated a quite a bit of interest and concern — from medical researchers, biotech companies, bioethicists and the average consumer alike.
NPR's Rob Stein explored many of the implications of this technology in his four-part series "The $1,000 Genome." They're complicated, to say the least.
Read more